Medicago中国区代理商/公司/官网
    • 网站首页
    • 公司简介
      公司简介
      企业文化
    • 产品展示
      细胞生物学产品
      分子生化产品
      免疫学产品
      植物学产品
    • 新闻动态
      公司新闻
      行业新闻
    • 成功案例
      成功案例
    • 客户服务
      售后服务
      技术支持
    • 人才招聘
    • 联系我们
      联系我们
      在线留言

    新闻动态Site navigation

    公司新闻
    行业新闻

    联系方式Contact


    地 址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
    电 话:17754422825
    网址:medicago.51antibodies.com
    邮 箱:sales@amyjet.com

    网站首页 > 新闻动态
    新闻动态Welcome to visit our

    艾美捷科技代理Helve端粒酶tica Health Care品牌全系列产品

    分享到:
      来源:Medicago中国区代理商/公司/官网  更新时间:2025-09-04 17:58:30  【打印此页】  【关闭】

    logo.jpg

    <

    艾美捷科技代理Helvetica Health Care品牌全系列产品


    Helvetica Health Care是一家位于瑞士日内瓦的医疗保健公司,致力于通过创新的捷科技代产品和技术来管理健康和提高生活质量。作为瑞士生物技术协会的理H列产成员,Helvetica Health Care通过了ISO 13485认证,品牌品在质量和创新方面坚持最高标准。全系涵盖各种质量控制和验证面板,艾美适用于不同的捷科技代分子测试平台和检测。这些产品有多种规格,理H列产可用于单一或多种分析物的品牌品检测,帮助实验室监控测试性能,全系确保测试的艾美准确性和可靠性。其质量控制和验证组合可根据产品配置、捷科技代填充量和分析物浓度进行定制,理H列产满足不同平台的品牌品需求。


    ▎Helvetica Health Care产品线

    Helvetica Health Care公司的产品涵盖:抗体、生命科学产品、血液分离产品、临床/诊断样本、质控品与标准品、分子生物学产品、细胞因子与生长因子、ELISA试剂盒/Western印迹相关产品、微生物、氧化应激产品、诊断产品以及人血浆制品。


    HelveticaHealthCare页面.png


    ▎Helvetica Health Care部分产品列表


    货号产品描述
    NATFRC-6CNATtrol Flu/RSV/SARS-CoV-2 Positive Control (6 x 0.5mL)
    NATCV9-6CNATtrol Flu/RSV/SARS-CoV-2 Negative Control (6 x 0.5mL)
    NATRPC2.1-BIONATtrol Respiratory Panel 2.1 (RP2.1) Controls (12 x 0.3mL)
    NATRVP2.1-BIONATtrol Respiratory Verification Panel 2.1 (24 x 0.6mL) (EA)
    NATRVP2.1-BIO PlusNATtrol Respiratory Verification Panel 2 Plus (+NATCOV(MR)-BIO) (24x 0.6 ml + 1x 0.6 ml)
    NATRVP2-QIANATtrol Respiratory Verification Panel 2 (21 x 0.25mL) (EA)
    NATSARS(COV2)-VPNATtrol SARS-CoV-2 Variant Panel (4 x 0.5mL)
    NATSARS(COV2)-ERCSARS-Related Coronavirus 2 (SARS-CoV-2) External Run Control (6 x 0.5 mL)
    NATSARS(COV2)-ERC1NATtrol SARS-Related Coronavirus 2 (SARS-COV-2) Positive Control (6x 1.0 ml)
    NATSARS(COV2)-NEGSARS-Related Coronavirus 2 (SARS-CoV-2) Negative Control (6 x 0.5 mL)
    NATSARS(COV2)-NEG1NATtrol SARS-Related Coronavirus 2 (SARS-COV-2) Negative Control (6x 1.0 ml)
    NATSARS(COV2)-STSARS-Related Coronavirus 2 (SARS-CoV-2) Stock
    NATSARS(COV2-SA)-STNATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.351 Stock (1mL)
    NATSARS(COV2-UK)-STNATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.1.7 Stock (1mL)
    0810229-0.5mgCoronavirus 229E Lysate (0.5 mg)
    0810587SARS-CoV-2 (Isolate: USA-WA1/2020) Lysate (1 mg)
    0810587-0.5mgSARS-CoV-2 (Isolate: USA-WA1/2020) Lysate (0.5 mg)
    0810587CFHI-0.5mLSARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (Heat Inactivated) (0.5 mL)
    0810587CFHISARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (Heat Inactivated) (1.0 mL)
    0810587UVSARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (UV Inactivated) (1 mL)
    0810589CFHISARS-CoV-2 (Isolate: Italy-INMI1) Culture Fluid (Heat Inactivated) (1 mL)
    0810589UVSARS-CoV-2 (Isolate: Italy-INMI1) Culture Fluid (UV Inactivated) (1 mL)
    0810590CFHISARS-CoV-2 (Isolate: Hong Kong/VM20001061/2020) Culture Fluid (Heat Inactivated) (1 mL)
    0810590UVSARS-CoV-2 (Isolate: Hong Kong/VM20001061/2020) Culture Fluid (UV Inactivated) (1 mL)
    0810617UVSARS-CoV-2 Lineage P1_2021; Gamma Variant (NY-Wadsworth-21033899-01/2021) Culture Fluid (UV))
    0810618UVSARS-CoV-2 Lineage P2_2021; Zeta Variant (NY-Wadsworth-21006055-01/2021) Culture Fluid (UV)
    0810619UVSARS-CoV-2 Iso1 Lin B.1.526_2021 Iota (NY-Wadsworth-21025952-01/2021) CF (UV Inactivated)
    0810620UVSARS-CoV-2 Iso2 Lin B.1.526_2021 Iota (NY-Wadsworth-21025952-01/2021) CF (UV Inactivated)
    0810621UVSARS-CoV-2 Lineage B.1_2020 (NY-Wadsworth-103677-01/2020) CF (UV Inactivated)
    0810622UVSARS-CoV-2 Lineage B.1.595_2020 (NY-Wadsworth-33126-01/2020) CF (UV Inactivated)
    0810612CFHISARS-CoV-2 Variant B.1.1.7 (Isolate:USA/CA_CDC_5574/2020) Culture Fluid (Heat Inactivated) (1 mL)
    0810612UVSARS-CoV-2 Lineage B.1.1.7; Alpha Variant (USA/CA_CDC_5574/2020) CF (UV Inactivated) (1 mL)
    0810613CFHISARS-CoV-2 Variant B.1.351(Isolate:South_Africa/KRISP-K005325/2020) CF (Heat Inactivated) (1 mL)
    0810613UVSARS-CoV-2 Lineage B.1.351; Beta (South_Africa/KRISP-K005325/2020) CF (UV Inactivated) (1 mL)
    0810614CFHISARS-CoV-2 Variant B.1.1.7 (Isolate:England/204820464/2020) Culture Fluid (Heat Inactivated) (1 mL)
    0810614UVSARS-CoV-2 Lineage B.1.1.7 Alpha Variant (England/204820464/2020) CF (UV Inactivated) (1 mL)
    0810616CFHISARS-CoV-2 Lineage P1; Gamma Variant (Japan/TY7-503/2021) CF (Heat Inactivated) (1 mL)
    0810616UVSARS-CoV-2 Lineage P1; Gamma Variant (Isolate: Japan/TY7-503/2021) CF (UV Inactivated) (1 mL)
    0810617CFHISARS-CoV-2 Lineage P1_2021; Gamma Variant (NY-Wadsworth-21033899-01/2021) – CFHI (1.0 ml)
    0810618CFHISARS-CoV-2 Lineage P2_2021; Zeta Variant (NY-Wadsworth-21006055-01/2021) – CFHI (1.0 ml)
    0810619CFHISARS-CoV-2 Lso1 Lin B.1.526_2021 Lota (NYWadsworth-21025952-01/2021) – CFHI (1.0 ml)
    0810620CFHISARS-CoV-2 Lso2 Lin B.1.526_2021 Lota (NYWadsworth-21025952-01/2021) – CFHI (1.0 ml)
    0810621CFHISARS-CoV-2 Lineage B.1_2020 (NY-Wadsworth-103677-01/2020) – CFHI (1.0 ml)
    0810622CFHISARS-CoV-2 Lineage E3.1.595J2020 (NYWadsworth-33126-01/2020) – CFHI (1.0 ml)
    0810623UVSARS-CoV-2 Lineage B.1.617.1 Kappa Variant (USA/CA-Stanford-15_S02/2021) CF (UV Inactivated)
    0810623CFHISARS-CoV-2 Lineage B.1.617.1 Kappa Variant (USA/CA-Stanford-15_S02/2021) CF (Heat Inactivated)
    0810624UVSARS-CoV-2 Lineage B.1.617.2; Delta Variant (USA/PHC658/2021) CF (UV Inactivated)
    0810624CFHISARS-CoV-2 Lineage B.1.617.2; Delta Variant (USA/PHC658/2021) CF (Heat Inactivated)
    0820010CFHIVeroE6 Culture Fluid (Heat Inactivated) (1 mL)
    0801043Goat Anti-SARS-CoV-2 Polyclonal Serum (0.5 ml)
    0831042SARS-CoV-2 (recombinant) Stock (1 x 1.0 mL)
    0831043SARS-CoV-2 (E/ORF1ab recombinant) Stock (1 x1.0mL)
    NATSARS-STCoronavirus SARS Stock (Qualitative) (1 mL)
    NATCOV(229E)-STCoronavirus 229E Stock (Qualitative) (1 mL)
    0810229CFHICoronavirus (Strain: 229E) Culture Fluid (Heat Inactivated) (1 mL)
    0810229Coronavirus Strain: 229E Lysate
    0810229UVCoronavirus (Strain: 229E) Culture Fluid (UV Inactivated) (1 mL)
    NATCOV(NL63)-STCoronavirus NL63 Stock (Qualitative) (1 mL)
    0810228CFHICoronavirus (Strain: NL63) Culture Fluid (Heat Inactivated) (1 mL)
    0810228Coronavirus Strain: NL63 Lysate
    0810228UVCoronavirus (Strain: NL63) Culture Fluid (UV Inactivated) (1 mL)
    NATCOV(OC43)-STCoronavirus OC43 Stock (Qualitative) (1 mL)
    0810024CFHICoronavirus (Strain: OC43) Culture Fluid (Heat Inactivated) (1 mL)
    0810024Coronavirus Strain: OC43 Lysate
    NATMERS-STMERS-CoV Stock (Qualitative) (1 mL)
    NATMR-BIONATtrol MERS Recombinant Pack (2x 0.2 ml +0.5 ml)
    NATCOV(MR)-BIONATtrol MERS-S. Cerevisiae (0.6 ml)
    0810575MERS-COV (Strain: Florida/USA-2_Saudi Arabia_2014) Lysate(1mg)
    0810575-0.5mgMERS-COV (Strain: Florida/USA-2_Saudi Arabia_2014) Lysate(0.5mg)
    CV033122COVID-19 Cross Over Panel (40x 1.0 ml)




    上一篇:艾美捷科技代理Assay Genie品牌
    下一篇:Electron Microscopy Sciences

    相关文章

    • 艾美捷科技代理Box scientific品牌全系列产品
    • 艾美捷科技代理Nexcelom品牌
    • 艾美捷科技代理Independent Forensics品牌全系列产品
    • 艾美捷科技代理Trialtusbioscience品牌全系列产品
    • Salimetrics
    • 艾美捷科技代理Astra Biotech品牌全系列产品
    • 艾美捷科技代理LifeSensors品牌
    • 艾美捷科技代理SYnAbs品牌抗体
    • ImmunoStar
    • 艾美捷科技代理Nanoanalytics品牌全系列产品

    友情链接:

    • invivoCrown IV0111替换BioXCell BE0036
    • invivoCrown IV0100替换BioXCell BE0146
    • invivoCrown IV0106替换BioXCell BE0090
    • invivoCrown IV0121替换BioXCell BE0001-1
    • invivoCrown IV0116替换BioXCell BE0016-2
    • invivoCrown IV0119替换BioXCell BE0004-1
    • invivoCrown IV0100替换BioXCell BE0146
    • invivoCrown IV0105替换BioXCell BE0089
    • invivoCrown IV0111替换BioXCell BE0036
    • invivoCrown IV0120替换BioXCell BE0015-1
    公司简介|产品展示|新闻动态|成功案例|客户服务|人才招聘|联系我们

    Copyright © 2025 Powered by Medicago中国区代理商/公司/官网   sitemap

    0.1877s , 7635.59375 kb